Drug ID: | NPD7728 |
Drug Name: | |
Molecular Formula: | C32H43N5O4 |
Canonical SMILES: | CN[C@H](C(=N[C@H]1CN(CC[C@@H]2N(C1=O)[C@@H](CC2)C(=NC(c1ccccc1)c1ccccc1)O)C(=O)CC(C)C)O)C |
Standard InCHI: | InChI=1S/C32H43N5O4/c1-21(2)19-28(38)36-18-17-25-15-16-27(37(25)32(41)26(20-36)34-30(39)22(3)33-4)31(40)35-29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-14,21-22,25-27,29,33H,15-20H2,1-4H3,(H,34,39)(H,35,40)/t22-,25+,26-,27-/m0/s1 |
Standard InCHIKey: | LSXUTRRVVSPWDZ-MKKUMYSQSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002247; DNCL003447 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 25022340 |
ChEBI | |
CAS Number |
Molecular Weight | 561.33 |
ALogP | -2.6169 |
MLogP | 3.99 |
XLogP | 6.394 |
HDA | 9 |
HBD | 3 |
Rotatable Bonds | 16 |
TPSA | 117.83 |
RO5 Violation | 1 |